Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging.

PURPOSE To determine if medial temporal lobe (MTL) atrophy rate, assessed by using an automated procedure over the initial time interval of a 6-year, three-time-point longitudinal study, is predictive of future memory decline. MATERIALS AND METHODS Healthy elderly subjects (age, >60 years) were administered a comprehensive battery of neuropsychometric tests and underwent magnetic resonance (MR) imaging at baseline and two or more follow-up examinations. The rate of brain atrophy between the baseline and first follow-up examinations was assessed by using an automated procedure that included spatial coregistration of the two images and regional brain boundary shift analysis. At final observation, the 45 subjects were separated into a group of those who did and a group of those who did not show objective evidence of cognitive decline. A forward stepwise logistic regression model was used to identify variables that predicted decline. RESULTS Thirty-two subjects remained healthy, and 13 showed cognitive decline. Among subjects who showed cognitive decline, six declined after the second observation. MTL atrophy rate, through its interactions with sex and age, was the most significant predictor of decline. The overall accuracy of prediction was 89% (in 40 of 45 subjects), with 91% specificity (in 29 of 32 subjects) and 85% sensitivity (in 11 of 13 subjects). CONCLUSION Among healthy elderly individuals, increased MTL atrophy rate appears to be predictive of future memory decline.

[1]  Matthew J. Hoptman,et al.  Age-related changes in brain: I. Magnetic resonance imaging measures of temporal lobe volumes in normal subjects , 2005, Psychiatric Quarterly.

[2]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[3]  Nick C Fox,et al.  Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial MRI , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[5]  N. Schuff,et al.  Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[6]  M. Bobinski,et al.  Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET) , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Convit,et al.  Hippocampal formation glucose metabolism and volume losses in MCI and AD , 2001, Neurobiology of Aging.

[8]  C. Fennema-Notestine,et al.  Effects of age on tissues and regions of the cerebrum and cerebellum , 2001, Neurobiology of Aging.

[9]  J. Price,et al.  Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.

[10]  C. Jack,et al.  Rates of hippocampal atrophy correlate with change in clinical status in aging and AD , 2000, Neurology.

[11]  C. Jack,et al.  Memory and MRI-based hippocampal volumes in aging and AD , 2000, Neurology.

[12]  E G Tangalos,et al.  Mild cognitive impairment. When is it a precursor to Alzheimer's disease? , 2000, Geriatrics.

[13]  M. Bobinski,et al.  The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease , 1999, Neuroscience.

[14]  Nick C Fox,et al.  Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease , 1999, The Lancet.

[15]  M N Rossor,et al.  Correlation between rates of brain atrophy and cognitive decline in AD , 1999, Neurology.

[16]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[17]  D. Jolley,et al.  Cost benefits of a medically supervised day treatment program for patients with Alzheimer's disease and other forms of dementia , 1989 .

[18]  M N Rossor,et al.  Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study. , 1998, Brain : a journal of neurology.

[19]  Scott T. Grafton,et al.  Automated image registration: I. General methods and intrasubject, intramodality validation. , 1998, Journal of computer assisted tomography.

[20]  Nick C Fox,et al.  Brain atrophy progression measured from registered serial MRI: Validation and application to alzheimer's disease , 1997, Journal of magnetic resonance imaging : JMRI.

[21]  C. Jack,et al.  Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease , 1997, Neurology.

[22]  A. Convit,et al.  Specific Hippocampal Volume Reductions in Individuals at Risk for Alzheimer’s Disease , 1997, Neurobiology of Aging.

[23]  M. Bobinski,et al.  Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease , 1997, Neurobiology of Aging.

[24]  W. Reddick,et al.  Establishing norms for age-related changes in proton T1 of human brain tissue in vivo. , 1997, Magnetic resonance imaging.

[25]  Nick C Fox,et al.  Accurate registration of serial 3D MR brain images and its application to visualizing change in neurodegenerative disorders. , 1996, Journal of computer assisted tomography.

[26]  M J de Leon,et al.  Hippocampal formation size predicts declining memory performance in normal aging , 1996, Neurology.

[27]  Nick C Fox,et al.  Visualisation and quantification of rates of atrophy in Alzheimer's disease , 1996, The Lancet.

[28]  P. S. St George-Hyslop,et al.  Prediction of probable Alzheimer's disease in memory-impaired patients , 1996, Neurology.

[29]  Daniel H. Mathalon,et al.  Age-related decline in MRI volumes of temporal lobe gray matter but not hippocampus , 1995, Neurobiology of Aging.

[30]  T. Crook,et al.  Estimated Prevalence of Age-Associated Memory Impairment Derived From Standardized Tests of Memory Function , 1994, International Psychogeriatrics.

[31]  W H Theodore,et al.  Measurement of whole temporal lobe and hippocampus for MR volumetry , 1993, Neurology.

[32]  H Rusinek,et al.  Brain Tissue Volume Measurement from Magnetic Resonance Imaging: A Phantom Study , 1993, Investigative radiology.

[33]  B. Reisberg,et al.  A Two-Year Longitudinal Study of Cognitive Function in Normal Aging and Alzheimer's Disease , 1993, Journal of geriatric psychiatry and neurology.

[34]  G. Rossa,et al.  [The Global Deterioration Scale (GDS) and Functional Assessment Staging (FAST) in the diagnosis of Alzheimer type dementia]. , 1993, Psychiatria polska.

[35]  P. Scheltens,et al.  Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[36]  Gwenn S. Smith,et al.  EARLY MARKER FOR ALZHEIMER'S DISEASE: THE ATROPHIC HIPPOCAMPUS , 1989, The Lancet.

[37]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[38]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[39]  B. Reisberg,et al.  The Global Deterioration Scale for assessment of primary degenerative dementia. , 1982, The American journal of psychiatry.

[40]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[41]  J. G. Gilbert,et al.  A Preliminary Report on a New Memory Scale , 1968, Perceptual and motor skills.